Top

Published in:

01-05-2020 | Coronavirus

COVID-19 and the eye immunity: lesson learned from the past and possible new therapeutic insights

Authors: Piergiorgio Neri, Francesco Pichi

Published in: International Ophthalmology | Issue 5/2020

Excerpt

Corona virus represents nowadays the hot topic in the scientific world due to the outbreak of a novel serotype formerly named coronavirus disease (COVID)-19 and now identified as severe acute respiratory syndrome (SARS)-COV-2 [1]. …

Seah I, Agarwal R (2019) Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm 28(3):391–395CrossRef

WHO (2020) WHO director-general’s opening remarks at the media briefing on COVID-19—11 March 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020. Accessed 11 April 2020

WHO (2020) Coronavirus disease 2019 (COVID-19) situation report—81. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200410-sitrep-81-covid-19.pdf?sfvrsn=ca96eb84_2. Accessed 11 April 2020

Colson P, Rolain JM, Lagier JC et al (2020) Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents. https://doi.org/10.1016/j.ijantimicag.2020.105932 CrossRefPubMedPubMedCentral

Sohrabi C, Alsafi Z, O’Neill N et al (2020) World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int J Surg 76:71–76CrossRef

Mehta P, McAuley DF, Brown M et al (2020) HLH across speciality collaboration, UK COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395(10229):1033–1034. https://doi.org/10.1016/s0140-6736(20)30628-0 CrossRefPubMed

Zhang C, Wu Z, Li JW et al (2020) The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality. Int J Antimicrob Agents. https://doi.org/10.1016/j.ijantimicag.2020.105954 CrossRefPubMedPubMedCentral

Robbins SG, Detrick B, Hooks JJ (1990) Retinopathy following intravitreal injection of mice with MHV strain JHM. Adv Exp Med Biol 276:519–524. https://doi.org/10.1007/978-1-4684-5823-7_72 CrossRefPubMed

Robbins SG, Detrick B, Hooks JJ (1991) Ocular tropisms of murine coronavirus (strain JHM) after inoculation by various routes. Invest Ophthalmol Vis Sci 32(6):1883–1893PubMed

10.

Zhao H, Shen D, Zhou H et al (2020) Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol [Online ahead of print]

11.

Yao XH, Li TY, He ZC et al (2020) A pathological report of three COVID-19 cases by minimally invasive autopsies. Zhonghua Bing Li Xue Za Zhi 49:E009 (in Chinese) PubMed

12.

Hooper LC, Chin MS, Detrick B, Hooks JJ (2005) Retinal degeneration in experimental coronavirus retinopathy (ECOR) is associated with increased TNF-alpha, soluble TNFR2 and altered TNF-alpha signaling. J Neuroimmunol 166(1–2):65–74CrossRef

13.

Fischer A, Antoniou KM, Brown KK et al (2015) “ERS/ATS task force on undifferentiated forms of CTD-ILD”. An official European respiratory society/American thoracic society research statement: interstitial pneumonia with autoimmune features. Eur Respir J 46(4):976–987CrossRef

14.

Xu J, Tan DY, Fu YY et al (2015) Do corticosteroids have a role in treating Ebola virus disease? Sci China Life Sci 58(1):111–113CrossRef

15.

Shang L, Zhao J, Hu Y et al (2020) On the use of corticosteroids for 2019-nCoV pneumonia. Lancet 395(10225):683–684CrossRef

16.

Stahl JP, Mailles A (2019) Herpes simplex virus encephalitis update. Curr Opin Infect Dis 32(3):239–243CrossRef

17.

Chaudhuri A, Kennedy PGE (2002) Diagnosis and treatment of viral encephalitis. Postgrad Med J 78:575–583CrossRef

18.

Smits SL, de Lang A, van den Brand JMA et al (2010) Exacerbated innate host response to SARS-CoV in aged non-human primates. PLoS Pathog 6(2):e1000756CrossRef

Title: COVID-19 and the eye immunity: lesson learned from the past and possible new therapeutic insights
Authors: Piergiorgio Neri
Francesco Pichi
Publication date: 01-05-2020
Publisher: Springer Netherlands
Keywords: Coronavirus
SARS-CoV-2
Published in: International Ophthalmology / Issue 5/2020
Print ISSN: 0165-5701
Electronic ISSN: 1573-2630
DOI: https://doi.org/10.1007/s10792-020-01389-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

COVID-19 and the eye immunity: lesson learned from the past and possible new therapeutic insights

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2020

Does TRABECULECTOMY meet the 10-10-10 challenge in PACG, POAG, JOAG and Secondary glaucomas?

A study of dry eye after cataract surgery in MGD patients

Protective effects of autophagy inhibitor 3-methyladenine on ischemia–reperfusion-induced retinal injury

Comparison of the effects of 180° and 360° applications of selective laser trabeculoplasty on intraocular pressure and cornea

Comparison of retinal layer thickness measurements obtained using two different swept-source optical coherence tomography imaging modes

Assessment of peripapillary vessel density in acute non-arteritic anterior ischemic optic neuropathy